Description Total budget of the call: EUR 140 million
The focus on innovation is reflected in the description of the objectives and scope of the specific topics, as well as in the expected impact statements. The innovation dimension of the proposals will be evaluated under the 'Impact' evaluation criterion.
Several topics tackling issues such as antimicrobial resistance, comparative effectiveness research, social innovation, support for SMEs and medical technologies have clear links to planned activities under Horizon 2020, especially with regard to the concerns of the citizens and the specific programmes "Tackling Societal Challenges" (TSC) and "Industrial Leadership and Competitive Frameworks" (ILCF). About half of the topics address issues of direct concern to citizens. More than half of the topics are related to TSC, several topics contribute to prepare the ground for ILCF in health (bio)technologies, all together with an indicative budget of over EUR 400 million.
Topics Called
- HEALTH.2013.0-1: Boosting the translation of health research projects' results into innovative applications for health.
- HEALTH.2013.2.3.1-1: Drugs and vaccines for infections that have developed or are at risk of developing significant anti-microbial
resistance.
Specific requirements to be considered under the evaluation:
- Specific innovation initiative designed to encourage strong SME efforts towards the translation of research results into innovative
applications for health.
- Leading role of SMEs in the project.
- Developing a short business plan as part of the proposal clearly describing the valorisation of the technology(ies) when presenting a full
proposal at stage 2.
- Expected outcomes of clear interest and potential benefit to SMEs
Eligibility:
The participation for this call is restricted to 3-5 "legal entities" established in different EU Member States and/or Associated countries. The entities must be independent of each other.
The EU Member States are:
Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, United Kingdom.
The Associated Countries are:
Albania, Bosnia and Herzegovina, Croatia, Faroe Islands, Macedonia, Iceland, Israel, Liechtenstein, Moldova, Montenegro, Norway, Serbia, Switzerland and Turkey
Target audience:
SMEs, Research institutes, Universities, Industry, (possibly) Potential end-users
Budget:
Total budget of the call: 140 million Euros
Deadline: 25 September 2012
For more info click here